Skip to main content
OpenTrials

Clinical trial condition

Mesothelioma

Explore clinical trials studying Mesothelioma. Study availability and eligibility vary by location and protocol.

181 public trials 33 recruiting studies
Refine in advanced search Browse all conditions

Mesothelioma trial results

Recruiting

APG-2449 in Patients With Advanced Solid Tumors

NCT03917043

Conditions
Adenoma, Adnexal Diseases, Advanced Solid Cancer, +39 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Sun-Yat Sen University Cancer Center Guangzhou, Guangdong, China
View Trial Details
Recruiting

SW-682 in Advanced Solid Tumors

NCT06251310

Conditions
Adenoma, Advanced Solid Tumor, Lung Diseases, +12 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • USC Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
  • UC San Diego Moores Cancer Center Sacramento, California, United States
  • UCLA Hematology-Oncology - Santa Monica Santa Monica, California, United States
View Trial Details
Recruiting

SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma

NCT05568680

Conditions
Adenoma, Adnexal Diseases, Cholangiocarcinoma Recurrent, +26 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Kansas Cancer Center Westwood, Kansas, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

Multidimensional Omics Analysis in Malignant Pleural Mesothelioma

NCT07561190

Conditions
Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations
  • Azienda Ospedaliera Universitaria Policlinico Rodolico San Marco di Catania Catania, Italy
  • Azienda Ospedaliera Universitaria Luigi Vanvitelli, Napoli Naples, Italy
  • Azienda USL IRCCS di Reggio Emilia Reggio Emilia, Italy
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS Roma, Italy
View Trial Details
Recruiting

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

NCT06362369

Conditions
ALK Genomic Tumor Aberrations, Adenocarcinoma, Adenoma, +69 more
Locations
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Florida Cancer Specialists Lake Mary, Florida, United States
  • Dartmouth Hitchcock Lebanon, New Hampshire, United States
  • Brown University Health Cancer Institute Providence, Rhode Island, United States
View Trial Details

Related conditions